AB-101
AB-101-01
Phase 2 small_molecule completed
Quick answer
AB-101 for Non Hodgkin Lymphoma is a Phase 2 program (small_molecule) at Artiva Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Artiva Biotherapeutics
- Indication
- Non Hodgkin Lymphoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed